| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Evaluation/monitoring | 11 | 4 | |
| Supraventricular tachycardia | 4 | 2 | |
| Vasovagal syncope | 4 | 1 | |
| Anxious mood | 1 | 0 | |
| Fainting | 1 | 1 |
Common side effects
| Side effect | Patients | Percentage |
|---|---|---|
| Injection site pain | 1 |
Side effect severity
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 0 | |
| Moderate | 1 | |
| Mild | 1 | |
| None | 3 |